ArticleBreast cancer research and treatment2009

Tolerability of and adherence to combination oral therapy with gefitinib and capecitabine in metastatic breast cancer.

E L Mayer et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.